These findings are consistent with the prior observation of decreased entry of CD36 into degradation pathways in macrophages from ob/ob mice, a model of obesity, insulin resistance and hyperinsulinemia [48] and with the in vitro observation that insulin prevents FA-dependent ubiquitination and degradation of CD36 [30]. The gene discussed is CD36; the disease is hyperinsulinism.